Synthesis of 1‐Phospho‐3‐benzoxepins via a Silver‐catalyzed Reaction of 2‐Alkynylacetophenones with Diazomethylphosphonates
Advanced Synthesis & Catalysis · 23.05.2023 · 365 (10) · 1580-1584
DOI: 10.1002/adsc.202300001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Synthesis & Catalysis, online erschienen am 26.04.2023. Verfasst von Rui She und 3 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Southwest University, National Natural Science Foundation of China, Natural Science Foundation of Chongqing.
Abstract (Originalsprache)
A synthetic protocol for construction of 3‐benzoxepin skeleton through a silver‐catalyzed annulation/nucleophilic/ring‐expansion reaction of 2‐alkynylacetophenones with diazomethylphosphonates is described. This protocol provided a series of 1‐phosphonate‐3‐benzoxepin analogs in yields of 39%–95%. The resulting benzoxepins featuring halogen and phosphonate could be further transformed into other derivatives. magnified image
Förderung
- Southwest University
- National Natural Science Foundation of China
- Natural Science Foundation of Chongqing
Zitieren
APA
She, R., Qiu, J., Liu, Y., & Peng, Y. (2023). Synthesis of 1‐Phospho‐3‐benzoxepins via a Silver‐catalyzed Reaction of 2‐Alkynylacetophenones with Diazomethylphosphonates. Advanced Synthesis & Catalysis, 365(10), 1580-1584. https://doi.org/10.1002/adsc.202300001
Vancouver
She R, Qiu J, Liu Y, Peng Y. Synthesis of 1‐Phospho‐3‐benzoxepins via a Silver‐catalyzed Reaction of 2‐Alkynylacetophenones with Diazomethylphosphonates. Advanced Synthesis & Catalysis. 2023;365(10):1580-1584. doi:10.1002/adsc.202300001
BibTeX
@article{She2023,
author = {She, Rui and Qiu, Jialin and Liu, Yan and Peng, Yungui},
title = {Synthesis of 1‐Phospho‐3‐benzoxepins via a Silver‐catalyzed Reaction of 2‐Alkynylacetophenones with Diazomethylphosphonates},
journal = {Advanced Synthesis & Catalysis},
year = {2023},
volume = {365},
number = {10},
pages = {1580--1584},
doi = {10.1002/adsc.202300001}
}
EUVIMED